Bioactivity Assessment of Poly(ɛ-caprolactone)/Hydroxyapatite Electrospun Fibers for Bone Tissue Engineering Application

Figure 3

(a) An EDX spectrum and (b) Ca distribution on PCL with 10% (w/w) nHA immersed in SBF after 7 days.

(a)

(b)